Arrowhead Pharmaceuticals
ARWR
#1801
Rank
$11.92 B
Marketcap
$84.65
Share price
-3.06%
Change (1 day)
431.39%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2026 (TTM): -$0.16 Billion USD

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are $0.62 Billion USD. In 2025 the company made an earning of $0.34 Billion USD, an increase over its 2024 earnings that were of -$0.61 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$0.16 Billion-146.31%
2025 $0.34 B-157.5%
2024 -$0.61 Billion112.45%
2023 -$0.29 Billion87.79%
2022 -$0.16 Billion-20.1%
2021 -$0.19 Billion67.59%
2020 -$0.12 Billion-347.53%
2019 $45.39 M-245.59%
2018 -$31.18 Million-13.17%
2017 -$35.91 Million-52.28%
2016 -$75.26 Million-16.57%
2015 -$90.2 Million30.32%
2014 -$69.21 Million171.62%
2013 -$25.49 Million16.56%
2012 -$21.87 Million107.53%
2011 -$10.54 Million
2008 -$37.11 Million-8.07%
2007 -$40.37 Million70.37%
2006 -$23.69 Million122.51%
2005 -$10.65 Million147.41%
2004 -$4.31 Million2002.28%
2003 -$0.21 Million-85.61%
2002 -$1.43 Million1371.97%
2001 -$0.1 Million-13.45%
2000 -$0.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$25.97 B-16,353.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-$3.12 Billion 1,847.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.19 B-219.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-$0.12 Billion-26.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$0.86 B-644.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-$87.21 Million-45.44%๐Ÿ‡บ๐Ÿ‡ธ USA